Patients are at the heart of everything we do here at Nemera. In order to keep up with patients' needs and how they can benefit most from our solutions innovation is key! 💡 Check out this short video explaining our innovation story, from concept to reality! Thank you Astorg for capturing our innovation story in such a beautiful way and to our innovation experts for their unwavering commitment 😊 #WePutPatientsFirst #penvario #capabilities #innovation
NEMERA’s Post
More Relevant Posts
-
Member NEMERA puts patients first. They employ a team of over 210 innovation experts in Europe and North America in order to keep up with patients' needs and better their products, such as the Penvario, a disposable variable-dose pen injector. Watch this short video to learn more about their innovation story. #membernews #penvario #innovation #patientsfirst
Patients are at the heart of everything we do here at Nemera. In order to keep up with patients' needs and how they can benefit most from our solutions innovation is key! 💡 Check out this short video explaining our innovation story, from concept to reality! Thank you Astorg for capturing our innovation story in such a beautiful way and to our innovation experts for their unwavering commitment 😊 #WePutPatientsFirst #penvario #capabilities #innovation
To view or add a comment, sign in
-
Timely insights are essential for maintaining the momentum of clinical trials. With Suvoda eCOA, real-time patient data is collected seamlessly, driving efficiency and value for CROs at every stage of a trial. In a recent Suvoda blog post, our VP of eCOA Practice, Andrés Escallón, discusses the power of high-quality and real-time data for CROs. By promptly entering and accessing important patient information and adjustments, such as protocol modifications, or addressing eConsent or eCOA compliance at specific sites, real-time data helps prevent costly delays. It also provides a clearer picture of the trial's progress and participants' status. Read more about how the Suvoda Platform provides real-time data access to CROs and sponsors at https://lnkd.in/e5ZXfGuT #Suvoda #clinicaltrials #clinicalresearch #eCOA #healthtech
To view or add a comment, sign in
-
Collecting quality data on patient outcomes is often one of the most important parts of a clinical trial. It is also challenging, and many eCOA solutions make it feel even more difficult with complicated processes, lack of questionnaire reusability, slow setup, and difficult-to-use tech. In a recent discussion, Suvoda's Vice President of eCOA Solutions Strategy, Andrés Escallón, shares insights on how to effectively utilize Suvoda eCOA to unlock high data quality and streamline compliance for both sites and patients. Discover how our eCOA solutions can enhance your clinical trials at https://lnkd.in/eWc_Geju #Suvoda #clinicaltrials #clinicalresearch #data #healthtech
To view or add a comment, sign in
-
Suvoda is proud to join Society for Clinical Research Sites (SCRS)’s Global Impact Partner (GIP) program to collaborate with research sites and industry partners, offering global expertise in alignment with the program’s mission. Our President and Chief Operating Officer, Robert Hummel, shares “As clinical trials increase in complexity and new technologies emerge, we are excited to work with SCRS and its member sites to transform the patient journey in a clinical trial. Our focus is on making our products more intuitive, robust, and streamlined so that site teams have the tools they need to calmly guide their patients through some of the most challenging moments of their lives.” Read more at https://lnkd.in/ewHYUaAB #Suvoda #clinicaltrials #clinicalresearch #healthtech
To view or add a comment, sign in
-
The first rule of tissue is: You do not talk about tissue. Gianni Gambini from Gambini S.p.A will talk about what is beyond tissue: empowered customers, unique products, our well-being and a planet asking for help. 📍Where: Tissue Planet - Future Insights™ | Lucca, Italy 📅 When: June 19, 2024 | 17:15 - 17:45 Main Stage Tissue Planet - Future Insights™ brings together the world's leading tissue producers and the technology supply chain industries to improve the environmental impact of the entire production line. Tissue Planet - Future Insights™ is an event organized by Toscotec, intended for tissue players across the globe and accessible by invitation only. A choice made to foster a more focused discussion environment, facilitate the engagement of the participants, and create authentic synergies. Following the event, the main insights that emerged will be made available. https://lnkd.in/dHdTf3sD #tissueplanet #tissueplanetfutureinsights #gambini
To view or add a comment, sign in
-
AI4MDR & Regulatory Thinking: YOUR Business Strategy in HEALTHTECH ETH Zürich * Carinthia University of Appl. Sciences * 4C Accelerator Germany Lecturer * Dipl. Lead Auditor * Lead Technical Assessor * CEO stimOS GmbH
AI4MDR and Tech Tour Growth/Health, Lausanne This year I was the moderator of the spit-fire session, highlighting the jungle of AI regulations in #Healthtech. A topic that we focus on at ETH Zürich and at Regulatory Thinking®. Starting with next Tuesday my collegue Niko Mangold an myself will share for you some smart #AI Tools, helping you to navigate regulations with assistance. #AI4MDR #RegulatoryThinking #dTIP Curious about this? Check it out NEXT TUESDAY: We will start a small series on #AI4MDR, #Tools, #Videos, #Webinars, #TemplateDocuments, #AI_Strategies … we want you to be successfull with your Business - but I have noticed so many cool products failing… See you soon!
🎉 𝐓𝐡𝐚𝐧𝐤 𝐲𝐨𝐮 𝐟𝐨𝐫 𝐚𝐧 𝐚𝐦𝐚𝐳𝐢𝐧𝐠 𝟏𝟓𝐭𝐡 𝐞𝐝𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐓𝐞𝐜𝐡 𝐓𝐨𝐮𝐫 𝐆𝐫𝐨𝐰𝐭𝐡 𝐇𝐞𝐚𝐥𝐭𝐡 𝐞𝐯𝐞𝐧𝐭! 🎉 We are thrilled to have successfully wrapped up the 15th edition of Tech Tour Growth Health! It was an incredible experience filled with innovation, collaboration, and inspiration. 🙌 Special appreciation goes to our leadership: - President: Fredrik Debong, OneTwenty.ai - Vice President: Tanja Dowe, Angelini Ventures ✨ Grateful to our partners: Etat de Vaud, Vaud Economie, Innovaud, Medtronic, Polyprime, TÜV SÜD, BioAlps - Swiss Health Valley, Biopôle Lausanne and Caresyntax for their unwavering support – none of this would have been possible without you! 🌟 A huge thank you to all the participants, especially the companies that pitched their groundbreaking ideas. Your passion and vision are what make this event so special! AbbatiaLabs, Agora Care SA, Aqsens Health, Aspivix, Axithra, Caresyntax, Cellply, Ceretrieve, CLOUDS OF CARE, Comphya, dacadoo, DIADEM SpA, genknowme, HBOX Therapies, Healium Medical, HelloBetter, HVR Cardio Oy (The rest of the companies are in the comments section). We look forward to connecting again in 2025 for another inspiring edition. Check out the amazing moments from our event—visit our website now to see all the photos! 🖼 ➡ https://lnkd.in/d2cn-hZ3 Let’s continue pushing the boundaries of innovation together! 💡🚀 #TTGH24 #tech #innovation #entrepreneurs #vcs #cvcs #venturecapital #venturefunding #investment #medtech #digitalhealth #diagnostics #investors
To view or add a comment, sign in
-
#ICYMI We unveiled the future of healthcare during our three keynote sessions at the #MedTechForum2023. We stepped into the forefront of medical innovation as Dr Jordan Nguyen, author, “A Human’s Guide to the Future”, provided us with a glimpse into the future with forward-looking predictions and advice on how we can unlock innovation’s potential by upgrading human capital. We also delved into the innovation journeys of two MedTech powerhouses, Terumo Asia Pacific and Roche Diagnostics Asia Pacific. Their leaders, Thomas Schinecker CEO, Roche Group and Shinjiro Sato, Global Group President & CEO, Terumo Corporation, in their respective keynote sessions and Lance Little, Head of Region, Roche Diagnostics Asia Pacific in a fireside chat with Harjit Gill, CEO APACMed, shared candid insights into the significance of innovation in the MedTech industry, and the importance of robust innovation strategies, effective management and organisational culture in ensuring the success of MedTech companies in an ever-evolving market. Missed the keynote sessions? Watch the recording here: https://lnkd.in/gMWuqd6M #MedTech #Innovation #Healthcare #FutureofHealthcare #MedTechForum2023 #HumanCapital #Leadership #Insights #APACMed
To view or add a comment, sign in
-
More great validation for portfolio company Karoo Health, which has been named to the New Mexico Inno 2024 Startups to Watch list. 👏 Karoo is transforming the current cardiac care model to improve patient outcomes and lower costs through a value-based approach that combines traditional, guideline-based care and state-of-the-art digital tools. Learn more about CEO Ian Koons and Karoo Health here ✴️ https://buff.ly/48fXvj8
To view or add a comment, sign in
-
It has been one year since the launch of the Suvoda Platform—a single, unified platform with three clinical trial products—purpose-built to minimize friction across the user experience for sponsors, CROs, sites, and patients. In this past year, the Suvoda Platform, surrounded by an industry-leading services team, has enabled seamless data sharing to drive decisions, customized workflows to reinforce precision, and provided dedicated support to minimize downtime in trials. The result? Better operational efficiency and smoother trials, allowing sponsors and study teams to focus on delivering lifesaving therapeutics to those who need them most. Learn more about how the Suvoda Platform can help your team unlock clinical trial efficiency at https://lnkd.in/ggvz6S2A #Suvoda #clinicaltrials #clinicalresearch #healthtech
To view or add a comment, sign in
-
Recommended talk if you are into MedTech 📲💯
I'm excited to be speaking at MedTech Summit 2024 this June in Brussels. I would be delighted to have many of you join me at the event! If you're interested in attending, register today and enjoy an exclusive 10% discount by using my referral code: MTCHSPK24. Click the following link to learn more: https://lnkd.in/eZRHuQbu . Informa Connect
To view or add a comment, sign in
25,902 followers
--
1moEmpresa muito boa de trabalhar pelo menos na minha época onde era a empresa milfra eu amava fazer parte dessa equipe. Eu operava a máquina retal como eu amava trabalhar lá, agora a nemera é difícil você ser notada no e-mail quando você envia currículo não obtive sucesso. Mas ainda tenho esperança.